The global sterile filtration was worth USD 4.9 billion in 2022 and is expected to reach USD 8.2 billion by 2030, and grows with a CAGR of 8.4% during the forecast period 2023-2030.
Industry Overview:
Sterile filtration is a procedure of removing microorganisms from a fluid stream without adversely affecting the product. Sterile filtration is used for many applications like media with or without serum. Sterile filters are used in drug development and other biological processes where the contamination is high and has to be prevented. Sterile filters are small pores sized to develop the filtration process. Sterile filters are available in various forms like syringes, cartridges, disposable sterile filter systems, and capsules for the perfect filtration of liquid and gases.
COVID-19 Impact on the Sterile Filtration Market:
The new infectious diseases, caused by the SARS-CoV-2, a novel coronavirus (COVID-19). The world pandemic has announced an emergency public health issue. The world economy has been severely affected and the structure of the market has changed. The pandemic has positively influenced the sterile filtration market and has surged the growth rate. Countries across the globe are extending and producing a vaccine for the novel coronavirus.
For developing the vaccine, huge capital is being invested by government bodies and different filtration procedures are being used to develop and produce vaccines. The U.K government invested USD 82.0 million in research in coronavirus and vaccine development for the COVID-19. Researchers are working fiercely to test a wide variety of capable COVID-19 treatments.
Market Drivers:
Factors involved in driving the sterile filtration market are the majority of the pharmaceutical, biotechnology, and other companies are highly spending on research and development activities. Growing chronic disease occurrences like diabetes, cancer, and heart problems with the rising patient population, and initial diagnosis of the disease and treatment stimulating the sterile filtration market growth. Approximately,55,122 new breast cancer cases were recorded in 2015, in the UK, as per Cancer Research.
The growing demand for biopharmaceutical applications upsurges the market growth during the timeline period. Developing new medicines for treating common health issues that have contributed to the consumption of medicines, and these kinds of developments across the pharmaceutical sector intensify the sterile filtration market growth globally.
Market Restraints: Excessively high-cost sterile filtration process obstructs the market growth over the forthcoming years.
STERILE FILTRATION MARKET REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2022 - 2030 |
Base Year |
2022 |
Forecast Period |
2023 - 2030 |
CAGR |
8.4% |
Segments Covered |
By Product, Membrane Pore Size, Membrane Type, Application, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
Key Companies Profiled |
Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), Parker Hannifin Corporation (US), Sterlitech Corporation (US), Alfa Laval AB (Sweden), and Thermo Fisher Scientific (US). |
The global sterile filtration market has been segmented and sub-segmented based on the product, application, membrane pore size, end-user, and membrane type.
Angioplasty Balloons
Cartridge filters
Capsule filters
Membranes
Syringe filters
Bottle-top & table-top filtration systems
Accessories
By product, most of the market share is held by the cartridge filters credited to the surging use of various numbers of filters for high procedures which requires more filtration area and less cost. The membrane filters product witnesses growth in the sterile filtration market as its applications for sterile filtration among both the pharmaceutical and biopharmaceutical labs is stimulating, and the kidney failure patient cases are surging, which fuels the sterile filtration market growth during the period.
2–0.22 µm
45 µm
1 µm
By pore size, 2-0.22 micron segment secures high potentiality. The segment growth ascribes to the growing need for the manufacturing of drugs and for eradicating microorganisms efficiently. The 45 microns segment will be the quickest growing segment owing to the growing use in research and analytical applications.
Polyethersulfone (PES)
Polyvinylidene difluoride (PVDF)
Nylon
Polytetrafluoroethylene (PTFE)
Mixed cellulose ester & cellulose acetate (MCE & CA)
Other materials
Based on the membrane type, the polyethersulfone (PES) segment held the largest share in 2019. The segment growth owes to the growing occurrence of atherosclerosis as an outcome of the growing frequency of obesity.
Fill-finish processes
Buffer filtration & cell culture media preparation
Bioburden reduction
Water purification
Air filtration
By application, the air filtration segment garner the highest revenue share in 2019 and continues to retain its dominance in the sterile filtration market by 2027. The growing adoption by the pharmaceuticals and active ingredients manufacturers for the dependable removal of particles and germs to stop contaminations and to confirm the purity of the product. The bioburden reduction segment will be the quick-growing segment in the sterile filtration market during the forecast period. The demand for monitoring bioburden to the processing of non-sterile bulk products is spurring to stop the excessive microbial load from reaching and fouling the sterilization. Also, it provides economic and equals the desired product quality swelling the sterile filtration market globally.
Pharmaceutical companies
Biopharmaceutical companies
Food & beverage companies
CMOs & CROs
Academic institutes & research laboratories
By end-user, pharmaceutical, and biopharmaceutical companies segment held a major share in terms of revenue and is in a position to grow with a CAGR of 4.8% during the forecast period. The usage of the sterile filtration process for addressing filtration and separation needs from research and development activities to initial stage product development propel the market's segment growth globally. CROs segment is planned to be the quickest-growing segment due to growing testing capacity and the existence absence of contaminating microorganisms with decreasing the turnover time and cross-contaminations threats.
Regionally, North America accounts for the largest share in the sterile filtration market in 2019 ascribed to the existing presence of a large number of pharmaceutical and biotechnology, and food and beverages industries, and well-equipped healthcare infrastructure. The biopharmaceutical companies have spent around 79.6 USD billion for research and development activities, as per the Pharmaceutical Research and manufacturers of America, in 2018. The number of API manufacturing facilities and companies investing in research and development activities is increasing, which in turn boom the sterile filtration market growth in the region. The U.S is likely to hold the dominant position in the sterile filtration market. In the U.S., around 510 API facilities in 2019, as per the US Food and Drug Administration (US FDA).
The European sterile filtration market observed to have prominent growth during the forecast period due to the technological advancements in nanofibers, surging generic market, and large molecules and biologics production is spurring.
Asia-Pacific is measured to be the swiftest growing region globally, due to the growing demand for generic drugs and biosimilars, and considerable investments by biopharmaceutical industries and CMOs. The concentration on healthcare modernization is mounting and the need for low-cost medicines escalate the sterile filtration market growth during the period.
Latin America and the Middle East & African regions are expected to have a constant growth rate in the sterile filtration market throughout the foreseen period.
Sterile Filtration Market - By Company Share
Major players operating in the sterile filtration market include
Merck KGaA (Germany)
Danaher Corporation (US)
Sartorius AG (Germany)
3M (US)
Parker Hannifin Corporation (US)
Sterlitech Corporation (US)
Alfa Laval AB (Sweden)
Thermo Fisher Scientific (US).
Recent Developments
On June 17, 2019, MilliporeSigma is scheduled to elevate the manufacture of filtration in New Hampshire, Jaffrey. To address the further requirements of the bioprocessing market, the approval process to expand the facility with extra cleanroom and lab. https://bioprocessintl.com/bioprocess-insider/upstream-downstream-processing/milliporesigma-plans-to-ramp-up-filtration-manufacture-in-nh/space over the next upcoming years.
Chapter 1. Sterile Filtration Market- Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Sterile Filtration Market- Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Sterile Filtration Market- Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. Sterile Filtration Market- Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 .Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Sterile Filtration Market- Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Sterile Filtration Market- By Product
6.1 Angioplasty Balloons
6.2 Cartridge filters
6.3 Capsule filters
6.4 Membranes
6.5 Syringe filters
6.6 Bottle-top & table-top filtration systems
6.7 Accessories
Chapter 7. Sterile Filtration Market- By Membrane Pore Size
7.1 2–0.22 µm
7.2 45 µm
7.3 1 µm
Chapter 8. Sterile Filtration Market- By Membrane Type
8.1 Polyethersulfone (PES)
8.2 Polyvinylidene difluoride (PVDF)
8.3 Nylon
8.4 Polytetrafluoroethylene (PTFE)
8.5 Mixed cellulose ester & cellulose acetate (MCE & CA)
8.6 Other materials
Chapter 9. Sterile Filtration Market- By Application
9.1 Fill-finish processes
9.2 Buffer filtration & cell culture media preparation
9.3 Bioburden reduction
9.4 Water purification
9.5 Air filtration
Chapter 10. Sterile Filtration Market- By End-User
10.1 Pharmaceutical companies
10.2 Biopharmaceutical companies
10.3 Food & beverage companies
10.4 CMOs & CROs
10.5 Academic institutes & research laboratories
Chapter 11. Sterile Filtration Market- By Region
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Latin America
11.5 The Middle East
11.6 Africa
Chapter 12. Sterile Filtration Market– Key players
12.1 Merck KGaA (Germany)
12.2 Danaher Corporation (US)
12.3 Sartorius AG (Germany)
12.4 3M (US)
12.5 Parker Hannifin Corporation (US)
12.6 Sterlitech Corporation (US)
12.7 Alfa Laval AB (Sweden)
12.8 Thermo Fisher Scientific (US).
2500
4250
5250
6900
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.